Bristol-Myers Squibb Company (BMY)
USD 56.84
(-1.41%)
USD 56.84
(-1.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 65.67 Billion USD | -0.04% |
| 2022 | 65.7 Billion USD | -10.38% |
| 2021 | 73.3 Billion USD | -9.05% |
| 2020 | 80.59 Billion USD | 3.01% |
| 2019 | 78.24 Billion USD | 964.72% |
| 2018 | 7.34 Billion USD | -66.14% |
| 2017 | 21.7 Billion USD | 25.02% |
| 2016 | 17.36 Billion USD | 0.21% |
| 2015 | 17.32 Billion USD | -7.68% |
| 2014 | 18.76 Billion USD | -19.65% |
| 2013 | 23.35 Billion USD | 4.93% |
| 2012 | 22.25 Billion USD | 30.15% |
| 2011 | 17.1 Billion USD | 10.79% |
| 2010 | 15.43 Billion USD | -4.84% |
| 2009 | 16.22 Billion USD | -6.29% |
| 2008 | 17.31 Billion USD | 10.9% |
| 2007 | 15.61 Billion USD | 0.17% |
| 2006 | 15.58 Billion USD | -7.95% |
| 2005 | 16.93 Billion USD | -16.32% |
| 2004 | 20.23 Billion USD | 14.41% |
| 2003 | 17.68 Billion USD | 11.18% |
| 2002 | 15.9 Billion USD | -2.54% |
| 2001 | 16.32 Billion USD | 94.34% |
| 2000 | 8.39 Billion USD | -0.84% |
| 1999 | 8.46 Billion USD | -2.61% |
| 1998 | 8.69 Billion USD | 12.09% |
| 1997 | 7.75 Billion USD | -4.4% |
| 1996 | 8.11 Billion USD | 0.1% |
| 1995 | 8.1 Billion USD | 12.5% |
| 1994 | 7.2 Billion USD | 16.96% |
| 1993 | 6.16 Billion USD | 28.78% |
| 1992 | 4.78 Billion USD | 32.12% |
| 1991 | 3.62 Billion USD | -4.64% |
| 1990 | 3.79 Billion USD | 11.25% |
| 1989 | 3.41 Billion USD | 2.65% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 77.57 Billion USD | -5.95% |
| 2024 Q3 | 76.47 Billion USD | -1.43% |
| 2024 Q1 | 82.48 Billion USD | 25.59% |
| 2023 Q4 | 65.67 Billion USD | 5.58% |
| 2023 Q3 | 62.2 Billion USD | 1.21% |
| 2023 Q2 | 61.45 Billion USD | -1.5% |
| 2023 FY | 65.67 Billion USD | -0.04% |
| 2023 Q1 | 62.39 Billion USD | -5.03% |
| 2022 FY | 65.7 Billion USD | -10.38% |
| 2022 Q1 | 71.38 Billion USD | -2.62% |
| 2022 Q2 | 67.69 Billion USD | -5.17% |
| 2022 Q3 | 65.46 Billion USD | -3.3% |
| 2022 Q4 | 65.7 Billion USD | 0.37% |
| 2021 Q3 | 73.6 Billion USD | -0.42% |
| 2021 Q2 | 73.92 Billion USD | -1.12% |
| 2021 FY | 73.3 Billion USD | -9.05% |
| 2021 Q1 | 74.76 Billion USD | -7.24% |
| 2021 Q4 | 73.3 Billion USD | -0.41% |
| 2020 Q2 | 78.91 Billion USD | -0.49% |
| 2020 Q4 | 80.59 Billion USD | 7.03% |
| 2020 Q3 | 75.3 Billion USD | -4.57% |
| 2020 Q1 | 79.3 Billion USD | 1.36% |
| 2020 FY | 80.59 Billion USD | 3.01% |
| 2019 Q4 | 78.24 Billion USD | 97.2% |
| 2019 Q1 | 9.99 Billion USD | 36.03% |
| 2019 Q2 | 30.35 Billion USD | 203.6% |
| 2019 FY | 78.24 Billion USD | 964.72% |
| 2019 Q3 | 39.67 Billion USD | 30.73% |
| 2018 Q2 | 20.22 Billion USD | 0.23% |
| 2018 Q1 | 20.17 Billion USD | -7.04% |
| 2018 FY | 7.34 Billion USD | -66.14% |
| 2018 Q4 | 7.34 Billion USD | -63.23% |
| 2018 Q3 | 19.98 Billion USD | -1.18% |
| 2017 Q4 | 21.7 Billion USD | 13.85% |
| 2017 Q3 | 19.06 Billion USD | 2.56% |
| 2017 Q2 | 18.58 Billion USD | 1.01% |
| 2017 Q1 | 18.4 Billion USD | 6.0% |
| 2017 FY | 21.7 Billion USD | 25.02% |
| 2016 Q1 | 17.34 Billion USD | 0.1% |
| 2016 Q2 | 17.75 Billion USD | 2.38% |
| 2016 Q3 | 17.94 Billion USD | 1.09% |
| 2016 Q4 | 17.36 Billion USD | -3.27% |
| 2016 FY | 17.36 Billion USD | 0.21% |
| 2015 Q2 | 16.66 Billion USD | -6.86% |
| 2015 Q3 | 16.5 Billion USD | -0.94% |
| 2015 Q4 | 17.32 Billion USD | 4.96% |
| 2015 FY | 17.32 Billion USD | -7.68% |
| 2015 Q1 | 17.89 Billion USD | -4.67% |
| 2014 FY | 18.76 Billion USD | -19.65% |
| 2014 Q1 | 17.89 Billion USD | -23.39% |
| 2014 Q2 | 18.12 Billion USD | 1.29% |
| 2014 Q3 | 18.24 Billion USD | 0.69% |
| 2014 Q4 | 18.76 Billion USD | 2.83% |
| 2013 Q2 | 21.87 Billion USD | -1.71% |
| 2013 Q1 | 22.25 Billion USD | 0.0% |
| 2013 FY | 23.35 Billion USD | 4.93% |
| 2013 Q4 | 23.35 Billion USD | 5.73% |
| 2013 Q3 | 22.09 Billion USD | 0.96% |
| 2012 Q1 | 16.16 Billion USD | -5.5% |
| 2012 Q3 | 22.14 Billion USD | 39.67% |
| 2012 Q4 | 22.25 Billion USD | 0.52% |
| 2012 FY | 22.25 Billion USD | 30.15% |
| 2012 Q2 | 15.85 Billion USD | -1.9% |
| 2011 Q3 | 15.57 Billion USD | -0.7% |
| 2011 Q4 | 17.1 Billion USD | 9.79% |
| 2011 FY | 17.1 Billion USD | 10.79% |
| 2011 Q1 | 14.95 Billion USD | -3.16% |
| 2011 Q2 | 15.68 Billion USD | 4.94% |
| 2010 Q1 | 15.52 Billion USD | -4.33% |
| 2010 FY | 15.43 Billion USD | -4.84% |
| 2010 Q4 | 15.43 Billion USD | -3.0% |
| 2010 Q3 | 15.91 Billion USD | 2.83% |
| 2010 Q2 | 15.47 Billion USD | -0.28% |
| 2009 Q4 | 16.22 Billion USD | -2.15% |
| 2009 Q1 | 16.56 Billion USD | -4.32% |
| 2009 Q2 | 15.87 Billion USD | -4.17% |
| 2009 FY | 16.22 Billion USD | -6.29% |
| 2009 Q3 | 16.58 Billion USD | 4.45% |
| 2008 Q1 | 15.76 Billion USD | 0.99% |
| 2008 Q3 | 15.53 Billion USD | -10.11% |
| 2008 Q2 | 17.28 Billion USD | 9.65% |
| 2008 FY | 17.31 Billion USD | 10.9% |
| 2008 Q4 | 17.31 Billion USD | 11.41% |
| 2007 Q1 | 15.83 Billion USD | 1.58% |
| 2007 Q2 | 16.41 Billion USD | 3.68% |
| 2007 Q3 | 14.94 Billion USD | -8.94% |
| 2007 Q4 | 15.61 Billion USD | 4.45% |
| 2007 FY | 15.61 Billion USD | 0.17% |
| 2006 Q1 | 15.9 Billion USD | -6.05% |
| 2006 FY | 15.58 Billion USD | -7.95% |
| 2006 Q3 | 15.62 Billion USD | -0.41% |
| 2006 Q2 | 15.69 Billion USD | -1.35% |
| 2006 Q4 | 15.58 Billion USD | -0.27% |
| 2005 FY | 16.93 Billion USD | -16.32% |
| 2005 Q1 | 18.02 Billion USD | -10.91% |
| 2005 Q2 | 14.43 Billion USD | -19.94% |
| 2005 Q3 | 14.34 Billion USD | -0.63% |
| 2005 Q4 | 16.93 Billion USD | 18.05% |
| 2004 Q1 | 17.82 Billion USD | 0.8% |
| 2004 FY | 20.23 Billion USD | 14.41% |
| 2004 Q4 | 20.23 Billion USD | 3.69% |
| 2004 Q3 | 19.51 Billion USD | 5.17% |
| 2004 Q2 | 18.55 Billion USD | 4.08% |
| 2003 Q4 | 17.68 Billion USD | 7.42% |
| 2003 FY | 17.68 Billion USD | 11.18% |
| 2003 Q1 | 16.06 Billion USD | 0.98% |
| 2003 Q2 | 16.3 Billion USD | 1.49% |
| 2003 Q3 | 16.46 Billion USD | 0.99% |
| 2002 Q1 | 14.18 Billion USD | -13.1% |
| 2002 Q2 | 14.06 Billion USD | -0.8% |
| 2002 FY | 15.9 Billion USD | -2.54% |
| 2002 Q3 | 15.77 Billion USD | 12.1% |
| 2002 Q4 | 15.9 Billion USD | 0.86% |
| 2001 Q4 | 16.32 Billion USD | 11.03% |
| 2001 FY | 16.32 Billion USD | 94.34% |
| 2001 Q3 | 14.7 Billion USD | 85.21% |
| 2001 Q2 | 7.93 Billion USD | -3.47% |
| 2001 Q1 | 8.22 Billion USD | -2.1% |
| 2000 FY | 8.39 Billion USD | -0.84% |
| 2000 Q1 | 8.22 Billion USD | -2.86% |
| 2000 Q2 | 7.91 Billion USD | -3.8% |
| 2000 Q3 | 8.31 Billion USD | 5.02% |
| 2000 Q4 | 8.39 Billion USD | 1.05% |
| 1999 Q3 | 8.17 Billion USD | 0.21% |
| 1999 Q4 | 8.46 Billion USD | 3.65% |
| 1999 FY | 8.46 Billion USD | -2.61% |
| 1999 Q2 | 8.15 Billion USD | -1.0% |
| 1999 Q1 | 8.23 Billion USD | -5.29% |
| 1998 Q2 | 7.34 Billion USD | -8.8% |
| 1998 FY | 8.69 Billion USD | 12.09% |
| 1998 Q1 | 8.05 Billion USD | 3.87% |
| 1998 Q3 | 7.37 Billion USD | 0.39% |
| 1998 Q4 | 8.69 Billion USD | 17.86% |
| 1997 FY | 7.75 Billion USD | -4.4% |
| 1997 Q3 | 7.79 Billion USD | 1.09% |
| 1997 Q4 | 7.75 Billion USD | -0.42% |
| 1997 Q1 | 8.09 Billion USD | -0.2% |
| 1997 Q2 | 7.7 Billion USD | -4.84% |
| 1996 Q3 | 7.65 Billion USD | -0.38% |
| 1996 Q1 | 7.88 Billion USD | -2.7% |
| 1996 Q2 | 7.68 Billion USD | -2.57% |
| 1996 FY | 8.11 Billion USD | 0.1% |
| 1996 Q4 | 8.11 Billion USD | 6.0% |
| 1995 Q4 | 8.1 Billion USD | 14.75% |
| 1995 Q2 | 7.36 Billion USD | -1.69% |
| 1995 Q1 | 7.49 Billion USD | 4.01% |
| 1995 FY | 8.1 Billion USD | 12.5% |
| 1995 Q3 | 7.06 Billion USD | -4.11% |
| 1994 FY | 7.2 Billion USD | 16.96% |
| 1994 Q1 | 6.28 Billion USD | 2.05% |
| 1994 Q2 | 6.24 Billion USD | -0.65% |
| 1994 Q4 | 7.2 Billion USD | 7.63% |
| 1994 Q3 | 6.69 Billion USD | 7.19% |
| 1993 Q3 | 4.71 Billion USD | 0.53% |
| 1993 Q1 | 4.36 Billion USD | -8.7% |
| 1993 Q4 | 6.16 Billion USD | 30.61% |
| 1993 Q2 | 4.69 Billion USD | 7.42% |
| 1993 FY | 6.16 Billion USD | 28.78% |
| 1992 Q1 | 3.42 Billion USD | -5.39% |
| 1992 FY | 4.78 Billion USD | 32.12% |
| 1992 Q4 | 4.78 Billion USD | 35.03% |
| 1992 Q3 | 3.54 Billion USD | 3.99% |
| 1992 Q2 | 3.4 Billion USD | -0.55% |
| 1991 FY | 3.62 Billion USD | -4.64% |
| 1991 Q1 | 3.62 Billion USD | -4.5% |
| 1991 Q2 | 3.62 Billion USD | -0.08% |
| 1991 Q3 | 3.57 Billion USD | -1.41% |
| 1991 Q4 | 3.62 Billion USD | 1.37% |
| 1990 Q2 | 3.68 Billion USD | 7.56% |
| 1990 FY | 3.79 Billion USD | 11.25% |
| 1990 Q1 | 3.42 Billion USD | 0.41% |
| 1990 Q3 | 3.75 Billion USD | 1.84% |
| 1990 Q4 | 3.79 Billion USD | 1.15% |
| 1989 FY | 3.41 Billion USD | 2.65% |
| 1989 Q4 | 3.41 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbbVie Inc. | 124.31 Billion USD | 47.171% |
| Bristol-Myers Squibb Company Ce | 65.67 Billion USD | 0.0% |
| Johnson & Johnson | 98.78 Billion USD | 33.518% |
| Eli Lilly and Company | 53.14 Billion USD | -23.581% |
| Merck & Co., Inc. | 69.04 Billion USD | 4.875% |
| Novartis AG | 53.19 Billion USD | -23.459% |
| Organon & Co. | 12.12 Billion USD | -441.507% |
| Pfizer Inc. | 137.21 Billion USD | 52.137% |